SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001594864-17-000015
Filing Date
2017-04-24
Accepted
2017-04-21 18:47:46
Documents
6
Period of Report
2017-04-21
Effectiveness Date
2017-04-24

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT juno-proxy2017.htm DEF 14A 1128823
2 ceopiechart.jpg GRAPHIC 44375
3 junorgb.jpg GRAPHIC 298001
4 neopiechart.jpg GRAPHIC 43024
5 proxycardpage1.jpg GRAPHIC 847120
6 proxycardpage2.jpg GRAPHIC 650661
  Complete submission text file 0001594864-17-000015.txt   3721841
Mailing Address 307 WESTLAKE AVENUE NORTH, SUITE 300 SEATTLE WA 98109
Business Address 307 WESTLAKE AVENUE NORTH, SUITE 300 SEATTLE WA 98109 2065821600
Juno Therapeutics, Inc. (Filer) CIK: 0001594864 (see all company filings)

IRS No.: 463656275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36781 | Film No.: 17776978
SIC: 2836 Biological Products, (No Diagnostic Substances)